Publications

Top-featured publications

Development of permeation enhancer-Co-loaded solid lipid nanoparticles for enhanced oral bioavailability of alendronate
Journal of Drug Delivery Science and Technology, 107320, 2025

Emerging Advances in Solid Tumor Immunotherapy: A Comparative Review of CAR-T, CAR-NK, CAR-M, and TIL Therapies

Yakhak Hoeji 69 (3), 212-223, 2025

Extracellular vesicle as therapeutic agents in anti-aging: Mechanistic insights and future potential

Journal of Controlled Release, 113796, 2025 (Top 5%)

Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy

Biomaterials 312, 122750, 2025  (Top 5%)

Enhancing glioblastoma therapy via intranasal administration of highly potent cell-penetrating peptide decorated nanoparticles

Journal of Controlled Release 378, 997-1012,  2025  (Top 5%)

Suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179

Nature Communications 16 (1), 1091, 2025  (Top 5%)

Recent advances in intranasal administration for brain-targeting delivery: a comprehensive review of lipid-based nanoparticles and stimuli-responsive gel formulations

International Journal of Nanomedicine, 1767-1807, 2024

Development and Characterization of Olaparib-Loaded Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) for Pharmaceutical Applications

AAPS PharmSciTech 25 (7), 221, 2024

Polyelectrolyte complex for drug delivery

Drug Targets and Therapeutics 3 (1), 62-73, 2024

Effects of PEG-linker chain length of folate-linked liposomal formulations on targeting ability and antitumor activity of encapsulated drug

International journal of nanomedicine, 1615-1630, 2023

High-dose paclitaxel and its combination with CSF1R inhibitor in polymeric micelles for chemoimmunotherapy of triple negative breast cancer

Nano Today 51, 101884, 2023  (Top 5%)

Development and characterization of pH-responsive nanocarriers for chemo-photothermal combination therapy of acidic tumors

Journal of Controlled Release 359, 52-68, 2023  (Top 5%)

RNA-Seq-guided triple-combination nano-system of gold nanocluster, quercetin, and docetaxel for ultimate synergistic photothermal-chemotherapy against MDR tumor

Nano Today 50, 101862, 2023  (Top 5%)

Tumor microenvironment stimuli-responsive lipid-drug conjugates for cancer treatment

International Journal of Pharmaceutics 639, 122942, 2023

Development of a sorafenib-loaded solid self-nanoemulsifying drug delivery system: Formulation optimization and characterization of enhanced properties

Journal of drug delivery science and technology 82, 104374, 2023

Nanomedicine approaches for medulloblastoma therapy

Journal of Pharmaceutical Investigation 53 (2), 213-233, 2023

Development and application of novel peptide-formulated nanoparticles for treatment of atopic dermatitis

Journal of Materials Chemistry B 11 (42), 10131-10146, 2023

Dynamic drug release state and PEG length in PEGylated liposomal formulations define the distribution and pharmacological performance of drug

Journal of Drug Delivery Science and Technology 76, 103825, 2022

Development of a pH-responsive polymer based on hyaluronic acid conjugated with imidazole and dodecylamine for nanomedicine delivery

Macromolecular Research 30 (8), 547-556, 2022

Nanoformulated remdesivir with extremely low content of poly (2‐oxazoline)‐based stabilizer for aerosol treatment of covid‐19

Macromolecular Bioscience 22 (8), 2200056, 2022

PEG-free polyion complex nanocarriers for brain-derived neurotrophic factor

Pharmaceutics 14 (7), 1391, 2022

Enhancing CDK4/6 inhibitor therapy for medulloblastoma using nanoparticle delivery and scRNA-seq–guided combination with sapanisertib

Science advances 8 (4), eabl5838, 2022  (Top 5%)

Drug‐dependent morphological transitions in spherical and worm‐like polymeric micelles define stability and pharmacological performance of micellar drugs

Small 18 (4), 2103552, 2022  (Top 5%)

Bioequivalence assessment of high-capacity polymeric micelle nanoformulation of paclitaxel and Abraxane® in rodent and non-human primate models using a stable isotope tracer assay

Biomaterials 278, 121140, 2021  (Top 5%)

Development of AE147 peptide-conjugated nanocarriers for targeting uPAR-overexpressing cancer cells

International journal of nanomedicine, 5437-5449, 2021

Preparation and characterization of a lutein solid dispersion to improve its solubility and stability

Aaps Pharmscitech 22 (5), 169, 2021

Poly (2-oxazoline) nanoparticle delivery enhances the therapeutic potential of vismodegib for medulloblastoma by improving CNS pharmacokinetics and reducing systemic toxicity

Nanomedicine: Nanotechnology, Biology and Medicine 32, 102345, 2021